ImmunoPrecise Antibodies
Earnings Surprise
Analysts estimated IPA earnings of $-0.05 per share this quarter (Q4). IPA's actual earnings were $-0.06 per share.
IPA EPS surprise of -9.14%Analysts estimated IPA earnings of $-0.08 per share this quarter (Q3). IPA's actual earnings were $-0.01 per share.
IPA EPS surprise of 87.62%Analysts estimated IPA earnings of $-0.10 per share this quarter (Q2). IPA's actual earnings were $-0.09 per share.
IPA EPS surprise of 6.25%Analysts estimated IPA earnings of $-0.11 per share this quarter (Q1). IPA's actual earnings were $-0.15 per share.
IPA EPS surprise of -35.01%Analysts estimated IPA earnings of $-0.12 per share this quarter (Q4). IPA's actual earnings were $-0.11 per share.
IPA EPS surprise of 5.34%Analysts estimated IPA earnings of $-0.10 per share this quarter (Q3). IPA's actual earnings were $-0.11 per share.
IPA EPS surprise of -8.91%Analysts estimated IPA earnings of $-0.13 per share this quarter (Q2). IPA's actual earnings were $-0.10 per share.
IPA EPS surprise of -23.84%